Knight Therapeutics Inc. (TSX:GUD)
9.45
+0.08 (0.85%)
Jun 26, 2026, 4:00 PM EST
Knight Therapeutics Employees
Knight Therapeutics had 830 employees as of December 31, 2025. The number of employees increased by 85 or 11.41% compared to the previous year.
Employees
830
Change (1Y)
85
Growth (1Y)
11.41%
Revenue / Employee
615.00K CAD
Profits / Employee
6.76K CAD
Market Cap
927.79M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Verano Holdings | 3,800 |
| Cronos Group | 610 |
| Canopy Growth | 960 |
| Cresco Labs | 2,900 |
| Cipher Pharmaceuticals | 5 |
| Green Thumb Industries | 4,900 |
| TerrAscend | 1,038 |
| Auxly Cannabis Group | 446 |
Knight Therapeutics News
- 10 days ago - Knight Therapeutics Announces Repayment of Revolving Credit Facility - GlobeNewsWire
- 4 weeks ago - Knight to Present at the Jefferies 2026 Healthcare Conference in New York City - GlobeNewsWire
- 4 weeks ago - Knight Therapeutics Announces Launch of TAVALISSE® in Mexico - GlobeNewsWire
- 6 weeks ago - Knight to Present at the 2026 RBC Capital Markets Global Healthcare Conference in New York City - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics price target raised to C$9.50 from C$8.50 at RBC Capital - TheFly
- 7 weeks ago - Knight Therapeutics resumed with a Buy at Canaccord - TheFly
- 7 weeks ago - Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil - GlobeNewsWire
- 7 weeks ago - Knight Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts